Abstract

The AcrB multidrug efflux transporter of E. coli is a giant homotrimeric membrane protein able to recognize and expel a wide variety of compounds out of the cell [1]. Obtaining the co-crystal structures of AcrB bound to its substrates has proven to be difficult, and to date only a few antibiotics have been successfully co-crystallized with the protein. From these studies, two main recognition sites were identified, but the small number of available co-crystal structures still hinders a full understanding of the molecular recognition mechanism. As a part of an extensive computational research activity on efflux pumps, we performed a systematic docking campaign to characterize the putative binding sites of antimicrobial compounds from different classes, namely carbapenems, cephalosporins, fluoroquinolones, penicillines, tetracyclines, and beta-lactamase inhibitors. In particular, for each compound we screened for possible binding sites on the whole protein, including thus possible binding pockets other than those already known. Flexibility has been taken into account by considering ensembles of rigid structures for both the ligand and the receptor. Ligand conformations have been extracted from microsecond-long molecular dynamics (MD) simulations in explicit water [2]. For the protein we considered a large set of conformations, including structures from both high-resolution X-ray and MD simulations. We present the results of this systematic investigation by comparing the patterns of interactions observed for the different compounds. The binding properties of the transporter are discussed in terms of statistics of the most contacted residues.1. P. Ruggerone, S. Murakami, K. M. Pos and A.V. Vargiu, Curr. Top. Med. Chem.13, 3079 (2013).2. G. Malloci, A. V. Vargiu, G. Serra, A. Bosin, P. Ruggerone, M. Ceccarelli, Molecules20, 13997 (2015).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.